Russell Investments Group, Ltd. Aptinyx Inc. Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$2.39 - $3.5 $164,475 - $240,863	-68,818 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$2.93 - $4.3 $90,827 - $133,295	30,999 Added 81.97%	68,818 $238,000
Q3 2020 Nov 09, 2020	SELL	$3.05 - $4.99 $7,466 - $12,215	-2,448 Reduced 6.08%	37,819 $127,000
Q2 2020 Aug 05, 2020	BUY	$1.99 - $4.4 $4,381 - $9,688	2,202 Added 5.78%	40,267 $167,000
Q1 2020 May 06, 2020	BUY	$1.81 - $5.03 $1,162 - $3,229	642 Added 1.72%	38,065 $81,000
Q4 2019 Jan 29, 2020	SELL	$2.84 - $4.25 $104,861 - $156,922	-36,923 Reduced 49.66%	37,423 $127,000
Q3 2019 Nov 01, 2019	BUY	$3.0 - $4.08 $223,038 - $303,331	74,346 New	74,346 $260,000
Q2 2019 Aug 09, 2019	SELL	$2.95 - $4.38 $18,528 - $27,510	-6,281 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.99 - $19.33 $25,061 - $121,411	6,281 New	6,281 $25,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.